Chemo-Senolytic Therapeutic Potential against Angiosarcoma.

Angiosarcoma is an aggressive soft-tissue sarcoma with a poor prognosis. Chemotherapy for this cancer typically employs paclitaxel, a taxane (genotoxic drug), although it has a limited effect owing to chemoresistance to prolonged treatment. In this study, we examine an alternative angiosarcoma treatment approach that combines chemotherapeutic and senolytic agents. We find that the chemotherapeutic drugs cisplatin and paclitaxel efficiently induce senescence in angiosarcoma cells. Subsequent treatment with the senolytic agent ABT-263 eliminates senescent cells by activating the apoptotic pathway. In addition, expression analysis indicates that senescence-associated secretory phenotype genes are activated in senescent angiosarcoma cells and that ABT-263 treatment downregulates IFN-I pathway genes in senescent cells. Moreover, we show that cisplatin treatment alone requires high doses to remove angiosarcoma cells. In contrast, lower doses of cisplatin are sufficient to induce senescence, followed by the elimination of senescent cells by the senolytic treatment. This study sheds light on a potential therapeutic strategy against angiosarcoma by combining a relatively low dose of cisplatin with the ABT-263 senolytic agent, which can help ease the deleterious side effects of chemotherapy.

[Usability Assessment of Information Feedback by Community Pharmacies in the Care of Outpatient Chemotherapy].

Sharing patient information between hospital and pharmacy is an important requirement to ensure safe and effective chemotherapy in outpatients. However, the usefulness of the information feedback from community pharmacies to the hospital has not been clarified. In this study, we analyzed feedback information with the aim of evaluating the usefulness of information feedback from pharmacies through a cooperation system based on information sharing in hospital and pharmacies. The type of information feedback was the most common side effect of supportive therapy, followed by confirmation/ inquiries of treatment contents, abnormality in clinical laboratory test values, etc. In total, 31.0% of the feedbacked information was information not described in the medical record. As a result of feedback of 38.0%, medication therapy was changed. Totally, 73.7% of the information not described in the medical record, but received through feedback, resulted in changes in medication therapy. The information feedback by sharing information on outpatient chemotherapy at pharmacies and hospitals was expected to contribute to patient safety and quality of life during outpatient chemotherapy.

Comparison of the estrogenic activities of seawater extracts from Suruga Bay, Japan, based on chemical analysis or bioassay.

The present study compared estrogenicity measured by in vitro bioassay and estrogenicity estimated by the chemical analysis of seawater from Suruga Bay, Japan. Nonylphenol, bisphenol A, estrone, 17beta-estradiol, nonhydroxy polycyclic aromatic hydrocarbons, and hydroxy polycyclic aromatic hydrocarbons, some of which show estrogenic activity, were selected as the target compounds. The yeast two-hybrid system was used to evaluate the estrogenic activities of seawater and chemicals with or without rat liver S9. Concentrations of estrogenic compounds in seawater were measured by chemical analysis using gas chromatography/ mass spectrometry. The main estrogenic compounds in seawater were estrone (< or = 9.2 ng/L), bisphenol A (< or = 1,070 ng/L), and nonylphenol (< or = 276 ng/L). The highest estrogenic activities in seawater were observed near a sewage treatment plant, but the predicted potencies based on the chemistry data were higher than those observed experimentally for the estrogenic activity in seawater. The estrogenicity measured by bioassay was raised considerably after S9 treatment; this observation was limited to the zone of freshwater immediately adjacent to the wastewater outfall.

Analysis of organotins in seawater of the Southern Ocean and Suruga Bay, Japan, by gas chromatography/inductively coupled plasma mass spectrometry.

Organotins are widespread in the world's oceans and have a detrimental effect on organisms. However, there is little information on their distribution in the Southern hemisphere. We analyzed organotins in seawater from the Southern Ocean and Suruga Bay, Japan, using gas chromatography/inductively coupled plasma mass spectrometry. Organotins were compared in two contrasting environments--one in shallow, temperate coastal waters (Suruga Bay) and the other in cold, deep waters of the far Southern Ocean. Twelve kinds of organotins were detected from Suruga Bay, with tributyltin (0.184-13.6 ng Sn/L) and total organotins (0.801-19.7 ng Sn/L). In contrast, three kinds of organotins were detected in the Southern Ocean, with total organotins (from not detected to 0.266 ng Sn/L). The ratios of degraded products of tributyltin and triphenyltin from the Southern Ocean were higher than those in Suruga Bay, suggesting that fresh input of organotins into the Southern Ocean is relatively low. The presence of butyltins in Antarctic sediments and biota has been demonstrated previously; however, the present study is the first to describe trace levels of organotins in the Southern Ocean approximately 1,000 km from Antarctica.

Down regulation of bisphenol A glucuronidation in carp during the winter pre-breeding season.

Environmental pollution by bisphenol A is prevalent in many rivers. The influence of bisphenol A on the reproductive organs of carp has been demonstrated to be serious, especially in the winter pre-breeding season. Although bisphenol A is detoxified as bisphenol A-glucuronide in carp organs, principally the intestine, the seasonal variation in the efficiency of the detoxification is not known. To estimate the seasonal risk of bisphenol A in carp, we investigated seasonal changes in microsomal UDP-glucuronosyltransferase activity toward bisphenol A in male-carp. Seasonal elimination efficiency of bisphenol A was also examined by organ perfusion in everted intestine. No marked seasonal differences were observed in UDP-glucuronosyltransferase activity toward 1-naphthol, but high activity toward sex steroid hormones (testosterone and estradiol) was observed in the winter pre-breeding season. Low UDP-glucuronosyltransferase activity toward bisphenol A was indicated in winter. The addition of bisphenol A into the mucosal fluid of the everted intestine resulted in excretion of bisphenol A into the mucosal side of the intestine as the metabolite, bisphenol A-glucuronide. Excretion of bisphenol A-glucuronide from carp intestine was highest in summer (proximal intestine: 13.3 nmol; middle intestine: 8.3 nmol; distal intestine: 7.9 nmol) and lowest in winter (proximal intestine: 1.0 nmol; middle intestine: 1.0 nmol; distal intestine: 0.9 nmol). These results suggest that metabolism and excretion of bisphenol A in carp hepatopancreas and intestine are impaired by down regulation of UDP-glucuronosyltransferase activity in the winter pre-breeding season.

Presence and estrogenicity of anthracene derivatives in coastal Japanese waters.

An analytical method was developed to measure levels of anthracene (ANT) and its derivative compounds 9,10-anthraquinone (ATQ) and eight hydroxy-anthraquinones (hATQs) in seawater from Tokyo Bay and Suruga Bay, Japan. The hATQs produced through photochemical reaction of ANT are known to be toxic. Seawater samples contained ANT at levels ranging from < 0.2 to 4.7 ng/L, ATQ from 3.9 to 200 ng/L, 1-hydroxyanthraquinone (1-hATQ) from < 0.9 to 5.3 ng/L, and 2-hATQ from 1.6 to 5.5 ng/L. The yeast two-hybrid system was also used to evaluate the estrogenic activity of these compounds. Estrogen agonist and antagonist tests with or without rat liver S9 were carried out. Some compounds showed estrogenic activity: The strongest (2-hydroxyanthraquinone) was of similar potency to p-nonylphenol. Concentrations of some estrogenic derivatives in the samples were higher than those of the parent ANT Polycyclic aromatic hydrocarbons (PAHs) such as ANT appear able to be transformed into toxic compounds in the environment when they are irradiated by sunlight, so it is important to monitor not only PAHs but also hydroxyl-PAH-quinones in the environment.

Evaluation of the Ishikawa cell line bioassay for the detection of estrogenic substances from sediment extracts.

This study examines the application of Ishikawa human endometrial adenocarcinoma cells to measure the estrogenic activity of fractionated extracts of sediments from Tokyo Bay, Japan. Estrogen stimulates alkaline phosphatase activity in this cell line. The results of these assays were compared with those of a yeast estrogen screen (YES) assay. The Ishikawa cell line bioassay showed higher sensitivity to 17beta-estradiol (median effective concentration [EC50], 10.7 pM) than did the YES assay (EC50, 480 pM). Fractionation of sediment extracts (all samples collected from 5 sites) showed that the nonpolar fraction was poisonous to yeast cells; the estrogenic activity of this fraction, therefore, could not be measured by YES. However, the nonpolar fraction did not kill the Ishikawa cells. The 17beta-estradiol-equivalent values of 15 extracts (3 fractions from each of 5 sediment samples) ranged from 5.7 to 697 pg/g dry weight according to the Ishikawa cell line bioassay. Chemical analysis using gas chromatography-mass spectrometry revealed that the highest concentrations of endocrine-disrupting chemicals were observed at the sampling station near the sewage treatment plant. The results support that the Ishikawa cell line bioassay is suitable for measuring the estrogenic activity of sediment samples.

In vivo visual reporter system for detection of estrogen-like substances by transgenic medaka.

Detection of endocrine disrupting chemicals, in particular, environmental estrogens with living organisms, has many advantages if compared to chemical analysis. The screening of novel pollutants with meaningful endpoints, the integration of uptake, bioconcentration, and excretion as well as the evaluation of endocrine disrupting effects with respect to toxicity require in vivo biotests for estrogen-like substances (ELSs). Critical disadvantages of whole organism biotests are their low sensitivity and the need for laborious and time-consuming work. To overcome these problems, we have developed a transgenic medaka strain harboring the green fluorescence protein (GFP) gene driven by choriogenin H gene regulatory elements. Choriogenin H is an egg envelope protein induced by estrogens in the liver. With yolk sac larvae of this strain, GFP induction in liver was observed 24 h after onset of aqueous exposure to 0.63 nM 17beta-estradiol (E2), 0.34 nM ethynylestradiol, or 14.8 nM estrone. Furthermore, concentrated sewage treatment effluent induced GFP expression. Comparison of E2 equivalents estimated by GFP-induction in transgenic medaka, a YES assay, and GC/MS showed detection limits in the same order of magnitude. These results indicated that the sensitivity of the transgenic medaka strain was sufficient for application as an alternative model in monitoring environmental water samples for ELSs.

Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats.

Cytokines have been implicated in the etiology or pathology of various psychiatric diseases of developmental origin such as autism and schizophrenia. Leukemia inhibitory factor (LIF) is induced by a variety of brain insults and known to have many influences on mature and immature nervous system. Here, we assessed the neurobehavioral and pathological consequences of peripheral administration of LIF in newborn rats. Subcutaneous LIF injection induced STAT3 phosphorylation in many brain regions and increased glial fibrillary acidic protein (GFAP) immunoreactivity in the neocortex, suggesting that LIF had direct effects in the central nervous system. The LIF-treated rats displayed decreased motor activity during juvenile stages, and developed abnormal prepulse inhibition in the acoustic startle test during and after adolescence. They displayed normal learning ability in active avoidance test, however. Brain neuronal structures and startle responses were grossly normal, except for the cortical astrogliosis during neonatal LIF administration. These results indicate that LIF induction in the periphery of the infant has a significant, but discrete impact on neurobehavioral development.